Ulcerative Colitis Medicine Market, Global Outlook and Forecast 2022-2028

June 2022 | 67 pages | ID: U0F50822D774EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Ulcerative Colitis Medicine in Global, including the following market information:

Global Ulcerative Colitis Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ulcerative Colitis Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

5-Aminosalicylic Acid Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ulcerative Colitis Medicine include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ulcerative Colitis Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ulcerative Colitis Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ulcerative Colitis Medicine Market Segment Percentages, by Type, 2021 (%)

• 5-Aminosalicylic Acid
• Corticosteroids
• Immunomodulator Drugs
• Biologics

Global Ulcerative Colitis Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ulcerative Colitis Medicine Market Segment Percentages, by Application, 2021 (%)

• Ulcerative Proctitis
• Proctosigmoiditis
• Left-Sided Colitis
• Pancolitis
• Acute Severe Ulcerative Colitis

Global Ulcerative Colitis Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ulcerative Colitis Medicine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ulcerative Colitis Medicine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ulcerative Colitis Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sumitomo
• Pfizer
• Novartis
• Merck
• Sanofi
• Johnson and Johnson
• GSK
• AstraZeneca
• Cipla
• Sun Pharm
• Allergan
• Teva Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ulcerative Colitis Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ulcerative Colitis Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ULCERATIVE COLITIS MEDICINE OVERALL MARKET SIZE

2.1 Global Ulcerative Colitis Medicine Market Size: 2021 VS 2028
2.2 Global Ulcerative Colitis Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ulcerative Colitis Medicine Players in Global Market
3.2 Top Global Ulcerative Colitis Medicine Companies Ranked by Revenue
3.3 Global Ulcerative Colitis Medicine Revenue by Companies
3.4 Top 3 and Top 5 Ulcerative Colitis Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ulcerative Colitis Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ulcerative Colitis Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Ulcerative Colitis Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ulcerative Colitis Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ulcerative Colitis Medicine Market Size Markets, 2021 & 2028
  4.1.2 5-Aminosalicylic Acid
  4.1.3 Corticosteroids
  4.1.4 Immunomodulator Drugs
  4.1.5 Biologics
4.2 By Type - Global Ulcerative Colitis Medicine Revenue & Forecasts
  4.2.1 By Type - Global Ulcerative Colitis Medicine Revenue, 2017-2022
  4.2.2 By Type - Global Ulcerative Colitis Medicine Revenue, 2023-2028
  4.2.3 By Type - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ulcerative Colitis Medicine Market Size, 2021 & 2028
  5.1.2 Ulcerative Proctitis
  5.1.3 Proctosigmoiditis
  5.1.4 Left-Sided Colitis
  5.1.5 Pancolitis
  5.1.6 Acute Severe Ulcerative Colitis
5.2 By Application - Global Ulcerative Colitis Medicine Revenue & Forecasts
  5.2.1 By Application - Global Ulcerative Colitis Medicine Revenue, 2017-2022
  5.2.2 By Application - Global Ulcerative Colitis Medicine Revenue, 2023-2028
  5.2.3 By Application - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ulcerative Colitis Medicine Market Size, 2021 & 2028
6.2 By Region - Global Ulcerative Colitis Medicine Revenue & Forecasts
  6.2.1 By Region - Global Ulcerative Colitis Medicine Revenue, 2017-2022
  6.2.2 By Region - Global Ulcerative Colitis Medicine Revenue, 2023-2028
  6.2.3 By Region - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ulcerative Colitis Medicine Revenue, 2017-2028
  6.3.2 US Ulcerative Colitis Medicine Market Size, 2017-2028
  6.3.3 Canada Ulcerative Colitis Medicine Market Size, 2017-2028
  6.3.4 Mexico Ulcerative Colitis Medicine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ulcerative Colitis Medicine Revenue, 2017-2028
  6.4.2 Germany Ulcerative Colitis Medicine Market Size, 2017-2028
  6.4.3 France Ulcerative Colitis Medicine Market Size, 2017-2028
  6.4.4 U.K. Ulcerative Colitis Medicine Market Size, 2017-2028
  6.4.5 Italy Ulcerative Colitis Medicine Market Size, 2017-2028
  6.4.6 Russia Ulcerative Colitis Medicine Market Size, 2017-2028
  6.4.7 Nordic Countries Ulcerative Colitis Medicine Market Size, 2017-2028
  6.4.8 Benelux Ulcerative Colitis Medicine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ulcerative Colitis Medicine Revenue, 2017-2028
  6.5.2 China Ulcerative Colitis Medicine Market Size, 2017-2028
  6.5.3 Japan Ulcerative Colitis Medicine Market Size, 2017-2028
  6.5.4 South Korea Ulcerative Colitis Medicine Market Size, 2017-2028
  6.5.5 Southeast Asia Ulcerative Colitis Medicine Market Size, 2017-2028
  6.5.6 India Ulcerative Colitis Medicine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ulcerative Colitis Medicine Revenue, 2017-2028
  6.6.2 Brazil Ulcerative Colitis Medicine Market Size, 2017-2028
  6.6.3 Argentina Ulcerative Colitis Medicine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue, 2017-2028
  6.7.2 Turkey Ulcerative Colitis Medicine Market Size, 2017-2028
  6.7.3 Israel Ulcerative Colitis Medicine Market Size, 2017-2028
  6.7.4 Saudi Arabia Ulcerative Colitis Medicine Market Size, 2017-2028
  6.7.5 UAE Ulcerative Colitis Medicine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sumitomo
  7.1.1 Sumitomo Corporate Summary
  7.1.2 Sumitomo Business Overview
  7.1.3 Sumitomo Ulcerative Colitis Medicine Major Product Offerings
  7.1.4 Sumitomo Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.1.5 Sumitomo Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Ulcerative Colitis Medicine Major Product Offerings
  7.2.4 Pfizer Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Ulcerative Colitis Medicine Major Product Offerings
  7.3.4 Novartis Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Ulcerative Colitis Medicine Major Product Offerings
  7.4.4 Merck Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Ulcerative Colitis Medicine Major Product Offerings
  7.5.4 Sanofi Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Johnson and Johnson
  7.6.1 Johnson and Johnson Corporate Summary
  7.6.2 Johnson and Johnson Business Overview
  7.6.3 Johnson and Johnson Ulcerative Colitis Medicine Major Product Offerings
  7.6.4 Johnson and Johnson Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.6.5 Johnson and Johnson Key News
7.7 GSK
  7.7.1 GSK Corporate Summary
  7.7.2 GSK Business Overview
  7.7.3 GSK Ulcerative Colitis Medicine Major Product Offerings
  7.7.4 GSK Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.7.5 GSK Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Ulcerative Colitis Medicine Major Product Offerings
  7.8.4 AstraZeneca Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 Cipla
  7.9.1 Cipla Corporate Summary
  7.9.2 Cipla Business Overview
  7.9.3 Cipla Ulcerative Colitis Medicine Major Product Offerings
  7.9.4 Cipla Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.9.5 Cipla Key News
7.10 Sun Pharm
  7.10.1 Sun Pharm Corporate Summary
  7.10.2 Sun Pharm Business Overview
  7.10.3 Sun Pharm Ulcerative Colitis Medicine Major Product Offerings
  7.10.4 Sun Pharm Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.10.5 Sun Pharm Key News
7.11 Allergan
  7.11.1 Allergan Corporate Summary
  7.11.2 Allergan Business Overview
  7.11.3 Allergan Ulcerative Colitis Medicine Major Product Offerings
  7.11.4 Allergan Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.11.5 Allergan Key News
7.12 Teva Pharmaceutical
  7.12.1 Teva Pharmaceutical Corporate Summary
  7.12.2 Teva Pharmaceutical Business Overview
  7.12.3 Teva Pharmaceutical Ulcerative Colitis Medicine Major Product Offerings
  7.12.4 Teva Pharmaceutical Ulcerative Colitis Medicine Revenue in Global Market (2017-2022)
  7.12.5 Teva Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ulcerative Colitis Medicine Market Opportunities & Trends in Global Market
Table 2. Ulcerative Colitis Medicine Market Drivers in Global Market
Table 3. Ulcerative Colitis Medicine Market Restraints in Global Market
Table 4. Key Players of Ulcerative Colitis Medicine in Global Market
Table 5. Top Ulcerative Colitis Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ulcerative Colitis Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ulcerative Colitis Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ulcerative Colitis Medicine Product Type
Table 9. List of Global Tier 1 Ulcerative Colitis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ulcerative Colitis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ulcerative Colitis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ulcerative Colitis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ulcerative Colitis Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ulcerative Colitis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ulcerative Colitis Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ulcerative Colitis Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue, (US$, Mn), 2023-2028
Table 30. Sumitomo Corporate Summary
Table 31. Sumitomo Ulcerative Colitis Medicine Product Offerings
Table 32. Sumitomo Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Ulcerative Colitis Medicine Product Offerings
Table 35. Pfizer Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Ulcerative Colitis Medicine Product Offerings
Table 38. Novartis Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Ulcerative Colitis Medicine Product Offerings
Table 41. Merck Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Ulcerative Colitis Medicine Product Offerings
Table 44. Sanofi Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Johnson and Johnson Corporate Summary
Table 46. Johnson and Johnson Ulcerative Colitis Medicine Product Offerings
Table 47. Johnson and Johnson Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 48. GSK Corporate Summary
Table 49. GSK Ulcerative Colitis Medicine Product Offerings
Table 50. GSK Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Ulcerative Colitis Medicine Product Offerings
Table 53. AstraZeneca Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Cipla Corporate Summary
Table 55. Cipla Ulcerative Colitis Medicine Product Offerings
Table 56. Cipla Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Sun Pharm Corporate Summary
Table 58. Sun Pharm Ulcerative Colitis Medicine Product Offerings
Table 59. Sun Pharm Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 60. Allergan Corporate Summary
Table 61. Allergan Ulcerative Colitis Medicine Product Offerings
Table 62. Allergan Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)
Table 63. Teva Pharmaceutical Corporate Summary
Table 64. Teva Pharmaceutical Ulcerative Colitis Medicine Product Offerings
Table 65. Teva Pharmaceutical Ulcerative Colitis Medicine Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ulcerative Colitis Medicine Segment by Type in 2021
Figure 2. Ulcerative Colitis Medicine Segment by Application in 2021
Figure 3. Global Ulcerative Colitis Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ulcerative Colitis Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ulcerative Colitis Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ulcerative Colitis Medicine Revenue in 2021
Figure 8. By Type - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 12. US Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 24. China Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ulcerative Colitis Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ulcerative Colitis Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. Sumitomo Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson and Johnson Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GSK Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cipla Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sun Pharm Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Allergan Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Teva Pharmaceutical Ulcerative Colitis Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)